News
Global Virus Network Experts Urge Rapid Regional Action as Bundibugyo Ebola Outbreak Raises Cross-Border Concern
TAMPA, FL, USA (May 19, 2026) – The Global Virus Network (GVN) calls for greater global financial, logistical and research support for the local response to the rare Bundibugjo Ebola virus outbreak in Africa. The spread of this virus, largely undetected, in the Ituri Province of the Democratic Republic of the Congo (DRC) was declared…
Read MoreHantavirus Cluster Linked to Cruise Ship Highlights Ongoing Zoonotic Risk and the Need for Vigilance
Hantavirus Cluster Linked to Cruise Ship Highlights Ongoing Zoonotic Risk and the Need for Vigilance Experts emphasize caution while underscoring the importance of environmental controls, early detection, and clear communication in travel settings TAMPA, FL, USA (May 5, 2026) – The Global Virus Network (GVN), representing eminent human and animal virologists from more than 90…
Read MoreGlobal Virus Network Statement on the Marburg Virus Outbreak in Ethiopia
Tampa, FL, USA, November 26, 2025: The Global Virus Network (GVN), a coalition of leading human and animal virologists in more than 40 countries dedicated to advancing pandemic preparedness through research, education and training, and global health solutions, today issued a statement on the newly confirmed outbreak of Marburg virus disease (MVD) in southern Ethiopia.…
Read MoreRespiratory Syncytial Virus: Newly Resurgent
December 5, 2022 Introduction We seem to be in a sort of Golden Age of respiratory viruses, including flu, SARS-CoV2 and respiratory syncytial virus (RSV). RSV is an enveloped negative strand RNA virus with a genome of approximately 15,000 nucleotides encoding 11 proteins. There are two serotypes, A and B, which can be discriminated by…
Read MoreGlobal Virus Network (GVN) Adds Thailand’s Mahidol University as Newest Member to Combat Viral Threats
Baltimore, Maryland, USA, October 26, 2022: The Global Virus Network (GVN), representing 68 Centers of Excellence and 11 Affiliates in 39 countries comprising foremost experts in every class of virus causing disease in humans, and the Mahidol University in Thailand announced the addition of the Mahidol Virus Network as GVN’s newest Center of Excellence. “We…
Read MoreAided by GVN and IHV, Kerala, India Celebrates Major Milestones to Advance Virus Research
Aided by GVN and IHV, Kerala, India Celebrates Major Milestones to Advance Virus Research October 6, 2022 During a conference attended by thousands, Dr. Gallo’s Malayalam Language Edition of “Virus Hunting” Was Released Thousands of students listened to Dr. Robert Gallo’s virtual lecture, “General Reflections on Pandemics and the Importance of the Global Virus Network…
Read MoreLangya Virus
Langya Virus August 15, 2022 A sentinel surveillance study in China has detected the zoonotic Langya henipavirus (Paramyxoviridae) in 35 patients. RNA of the virus was found in 27% of shrews in the wild, revealing a potential animal reservoir. Zoonotic transmission is the first step potentially leading to “jumps” across species. Currently, there is no evidence of…
Read MoreWorld Hepatitis Day 2022
Hundreds of millions of people worldwide are affected by viral hepatitis. Chronic hepatitis B and C are estimated to affect half a billion of people. Many more are affected by acute hepatitis, especially in developing countries, resulting in significant symptoms, including death. Recently, clusters of cases of non A-E viral hepatis have raised concerns, and…
Read MoreGlobal Virus Network (GVN) Convenes First-Of-Its-Kind Conference To Evaluate The Public Health Magnitude Of Long-COVID And Define A Global Research Roadmap To Address The Crisis
World Leaders in Science, Healthcare, Academia, Business and Government Discuss Issues and Ramifications of Long Covid Baltimore, MD, USA (July 22, 2022) – The Global Virus Network (GVN), a coalition of world leading medical virology research centers, yesterday concluded a two-day gathering on the ‘Science of Long COVID.’ The first-of-its-kind conference reviewed the wealth of cohort…
Read MoreGVN Statement on SARS-CoV-2 Variant BA.2.75
There is some concern about the new SARS-CoV-2 variant BA.2.75. Very preliminary data on this variant suggests high growth advantage when compared to earlier variants. The N460K mutation in the Spike protein has been suggested as distinctive, conferring growth advantage to pseudotype virions. Epidemiologists around the world are aware of this variant, and the GVN…
Read More